2016
DOI: 10.18632/oncotarget.9736
|View full text |Cite
|
Sign up to set email alerts
|

Study of single nucleotide polymorphisms of FBW7 and its substrate genes revealed a predictive factor for paclitaxel plus cisplatin chemotherapy in Chinese patients with advanced esophageal squamous cell carcinoma

Abstract: Paclitaxel plays a major role in the treatment of advanced esophageal squamous cell carcinoma. However, there is no biomarker that could be used to predict the clinical response of paclitaxel. This work was conducted to investigate the association of genetic polymorphisms in FBW7 and its substrate genes and the clinical response of paclitaxel. Patients with advanced esophageal squamous cell carcinoma were treated with paclitaxel 175 mg/m2 over 3 hours day 1 and cisplatin 75 mg/m2 day 1, every 3 weeks. The geno… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
2
0

Year Published

2016
2016
2019
2019

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 35 publications
1
2
0
Order By: Relevance
“…Other authors have shown that mTOR can be used as a substrate protein of FBW7 and can be modified by ubiquitination and degraded by proteasomes [9]. Our study confirmed that FBW7 plays a role similar to rapamycin to enhance the autophagy level by degradation of mTOR.…”
Section: Discussionsupporting
confidence: 87%
See 1 more Smart Citation
“…Other authors have shown that mTOR can be used as a substrate protein of FBW7 and can be modified by ubiquitination and degraded by proteasomes [9]. Our study confirmed that FBW7 plays a role similar to rapamycin to enhance the autophagy level by degradation of mTOR.…”
Section: Discussionsupporting
confidence: 87%
“…Moreover, the level of autophagy was lower in DN mouse than in normal mice [8]. P13K-Akt-mTOR constitutes the most common negative-regulatory signaling pathway of the cell; mTOR, the substrate of FBW7, can be modified by ubiquitination and degraded by proteasomes [9].…”
Section: Introductionmentioning
confidence: 99%
“…For example, one study identified that SNPs of interferon regulatory factor-4 (IRF4) were associated with melanoma development [ 13 ]. Another study validated that SNPs of F-box and WD repeat domain containing 7 (FBW7) could be the predictive factor for paclitaxel plus cisplatin chemotherapy in patients with advanced esophageal squamous cell carcinoma [ 14 ]. Moreover, SNP of WWOX was found to represent a major predictive factor in gemcitabine-treated pancreatic cancer [ 15 ].…”
Section: Introductionmentioning
confidence: 99%